12.25London

Saturday, 26 October 2024

At last! Pill is found to relieve the agony of lower back pain

The treatment called tanezumab, which inhibits nerve activity, has been found to aid one of the leading causes of disability worldwide. Scientists say it could bring long-term relief to a third of those in agony every day. Lead researcher Dr John Markman, of the University of Rochester, New York state, said:…

Coronavirus update: The NHS test and trace scam you need to be aware of

The NHS test and trace service ensures anyone who develops symptoms of coronavirus can be quickly tested to find out if they have the virus, and helps trace close recent contacts of anyone who tests positive. But people are being urged to be on their guard against criminals trying to…

Recall the case of Afri-Cola: bottles can Burst

Niehoffs Vaihinger fruit juice GmbH calls afri Cola is 10 mg of caffeine, and afri Cola without the sugar in the 1 l glass bottle with shelf life expiration dates 12.03.2021 and 13.03. 2021,16.03.2021 and 17.03.2021 and 08.06.2021 and 09.06.2021 because of the risk of a possible glass break, back….

Why we need to learn to live with COVID-19

Measles infected people for 1,500 years, killing more than one million people annually during the 20th century alone before John Enders and Thomas Peebles isolated the virus in 1954 and developed a vaccine nine years later. Four decades onward again, the disease was finally eliminated from North America. But for…

Higher rates of severe COVID-19 in BAME populations remain unexplained

Higher rates of severe COVID-19 infections in Black, Asian, and Minority Ethnic (BAME) populations are not explained by socioeconomic or behavioral factors, cardiovascular disease risk, or by vitamin D status, according to new research led by Queen Mary University of London. The findings, published in the Journal of Public Health,…

Research on multiple sclerosis, gait to lead to more effective fall prevention

People who are diagnosed with multiple sclerosis (MS), a chronic neurological disease that affects the body’s central nervous system, often experience difficulty in maintaining body balance while walking and are at a greater risk of falling. Dean’s Doctoral Fellow Meng-Wei Lin and CEHD Assistant Professor Feng Yang conducted a study…

Team finds convalescent plasma safe for diverse patients with COVID-19

Mayo Clinic researchers and collaborators have found investigational convalescent plasma to be safe following transfusion in a diverse group of 20,000 patients. The findings—from the U.S. Food and Drug Administration’s Expanded Access Program for COVID-19—are reported in Mayo Clinic Proceedings. The safety report assessed the seven days following transfusion for…